ASPCA Warns of Acrylamide Toxicity Risks in Consumer Cooling Products
Event summary
- ASPCA research published in JAVMA reveals severe cases, including death, linked to ingestion of polyacrylamide-based hydrogel products in 45 dogs.
- Acrylamide levels in cooling gel products found to be 21-86 times higher than expected, with some products containing 12,900-51,800 ppm.
- ASPCA Poison Control reports weekly cases of suspected acrylamide toxicosis from consumer products like migraine caps, eye masks, wraps, and dog beds.
- No antidote exists for acrylamide toxicosis; treatment focuses on controlling symptoms and supportive care.
The big picture
The ASPCA's findings highlight a significant gap in consumer product safety, particularly in items containing hydrogel. This research could trigger broader industry scrutiny of manufacturing processes and safety standards for products marketed as nontoxic. The high levels of acrylamide detected suggest potential risks not just for pets but also for humans, raising questions about current regulatory oversight and the need for stricter guidelines in the consumer goods sector.
What we're watching
- Regulatory Response
- Whether regulatory bodies will establish limits on acrylamide in polyacrylamide hydrogel products to protect animals and humans.
- Industry Impact
- How this research will affect the consumer cooling products market, particularly brands using hydrogel materials.
- Treatment Advances
- The pace at which ASPCA Poison Control and other experts develop more effective treatment options for acrylamide toxicosis.
